This study reveals that EGFR–SGLT1 may confer a survival advantage to cancer cells by maintaining a basallevel of intracellular glucose and preventing autophagy.
It has long been thought that there are two levels of decision-making: a conscious level taking place in the cerebral cortex and an unconscious level in the basal ganglia.